Tempus operates a CLIA-certified sequencing laboratory and an AI platform that integrates multimodal data — including next-generation sequencing (NGS), imaging, pathology, and de-identified clinical records — to train and deploy clinical-grade machine learning models. The platform exposes APIs and a data licensing layer that allows biopharma partners and academic institutions to query structured real-world datasets for research and trial matching. Tempus's models cover tumor profiling, transcriptomics, HRD scoring, and AI-based radiology and pathology analysis.